216 related articles for article (PubMed ID: 33942483)
41. Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma.
Wang S; Wu C; Ma D; Hu Q
PeerJ; 2021; 9():e11233. PubMed ID: 33954048
[TBL] [Abstract][Full Text] [Related]
42. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
Chang K; Yuan C; Liu X
Front Oncol; 2021; 11():649347. PubMed ID: 33996565
[TBL] [Abstract][Full Text] [Related]
43. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
Li Z; Yu B; Qi F; Li F
Front Oncol; 2021; 11():670218. PubMed ID: 33968780
[TBL] [Abstract][Full Text] [Related]
44. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
Front Oncol; 2021; 11():639600. PubMed ID: 33968738
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment.
Zhang Y; Yang F; Peng X; Li X; Luo N; Zhu W; Fu M; Li Q; Hu G
Front Cell Dev Biol; 2021; 9():665364. PubMed ID: 33959617
[No Abstract] [Full Text] [Related]
46. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
[TBL] [Abstract][Full Text] [Related]
47. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J
Front Oncol; 2021; 11():654350. PubMed ID: 33954112
[TBL] [Abstract][Full Text] [Related]
48. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.
Li L; Xia S; Shi X; Chen X; Shang D
Sci Rep; 2021 May; 11(1):10728. PubMed ID: 34021184
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
Zhu G; Huang H; Xu S; Shi R; Gao Z; Lei X; Zhu S; Zhou N; Zu L; Mello RA; Chen J; Xu S
Thorac Cancer; 2021 Jun; 12(12):1890-1899. PubMed ID: 33979897
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
Fan T; Liu Y; Liu H; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Cancer Immunol Immunother; 2021 Dec; 70(12):3651-3667. PubMed ID: 33977344
[TBL] [Abstract][Full Text] [Related]
51. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Zhong W; Zhang F; Huang C; Lin Y; Huang J
J Cancer; 2021; 12(11):3265-3276. PubMed ID: 33976736
[TBL] [Abstract][Full Text] [Related]
52. Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma.
Zhan C; Wang Z; Xu C; Huang X; Su J; Chen B; Wang M; Qi Z; Bai P
Front Mol Biosci; 2021; 8():609865. PubMed ID: 33968978
[TBL] [Abstract][Full Text] [Related]
53. Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis.
Tu Z; He X; Zeng L; Meng D; Zhuang R; Zhao J; Dai W
Front Genet; 2021; 12():647521. PubMed ID: 33968130
[TBL] [Abstract][Full Text] [Related]
54. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study.
Zou W; Wang Z; Wang F; Zhang G; Liu R
BMC Cancer; 2021 May; 21(1):524. PubMed ID: 33964898
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer.
Dai ZT; Xiang Y; Wang Y; Bao LY; Wang J; Li JP; Zhang HM; Lu Z; Ponnambalam S; Liao XH
Aging (Albany NY); 2021 May; 13(10):13876-13897. PubMed ID: 33962392
[TBL] [Abstract][Full Text] [Related]
56. YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect.
Hou Y; Zhang Q; Pang W; Hou L; Liang Y; Han X; Luo X; Wang P; Zhang X; Li L; Meng X
Cell Death Differ; 2021 Nov; 28(11):3105-3124. PubMed ID: 34021267
[TBL] [Abstract][Full Text] [Related]
57. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
[TBL] [Abstract][Full Text] [Related]
58. An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Feng Z; Li K; Lou J; Wu Y; Peng C
Front Cell Dev Biol; 2021; 9():665161. PubMed ID: 33996821
[TBL] [Abstract][Full Text] [Related]
59. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients.
Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988674
[TBL] [Abstract][Full Text] [Related]
60. A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
Wu L; Wen Z; Song Y; Wang L
J Cell Mol Med; 2021 Jun; 25(12):5681-5690. PubMed ID: 33987935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]